EUVIMEDEUVIMED entdecken
Crossref

Comparison of the high‐dose dual therapy and standard quadruple therapy methods containing bismuth as the first line of treatment in eradicating Helicobacter pylori infection in Iran: A clinical trial study

Shahriar Nikpour, Mohammad Salehi, Maryam Abbasi, Ako Ghahremani, Sholeh Tavakoly Shiraji, Sara Abasi, Mohsen Rokni

Advances in Digestive Medicine · 2026-09 · 13 (3)

DOI: 10.1002/aid2.70042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Digestive Medicine, online erschienen am 10.11.2026. Verfasst von Shahriar Nikpour und 6 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Helicobacter pylori ( H. pylori ) infection is one of the most common infections in the world, which causes various complications, including abdominal pain and cancer. There are two methods for H. pylori treatment: standard quadruple therapy with bismuth subcitrate (BQT) and high‐dose dual therapy (HDDT). This study aimed to compare these two treatment methods with each other in patients with H. pylori infection. This quasi‐randomized clinical trial study was conducted on 101 patients receiving the BQT and 105 patients with HDDT methods in Loqhman hospital in Iran. The first and second intervention groups (BQT and HDDT), respectively, were undergoing treatment with standard quadruple with amoxicillin (1 g), pantoprazole (20 mg), metronidazole (1 g), and bismuth subcitrate (240 mg) and HDDT with amoxicillin (1 g) and pantoprazole (40 mg) for 14 days. After 4 weeks, the effectiveness of the therapy methods in eradicating H. pylori was assessed by ELISA method by examining the antigen of H. pylori in feces. The mean age of patients in the BQT group was 42.2 years and in the HDDT group was 42.7 years. The 82% in the BQT group and 79% in the HDDT group had negative fecal antigens H. pylori after 2 weeks of treatment. Although the efficacy rate of HDDT treatment was relatively higher in the HDDT group, the difference between these two groups was not statistically significant ( p = .5). The study results indicated that BQT therapy is not significantly more effective than HDDT therapy, and their effects are similar.

Zitieren

APA

Nikpour, S., Salehi, M., Abbasi, M., Ghahremani, A., Shiraji, S. T., Abasi, S., & Rokni, M. (2026). Comparison of the high‐dose dual therapy and standard quadruple therapy methods containing bismuth as the first line of treatment in eradicating Helicobacter pylori infection in Iran: A clinical trial study. Advances in Digestive Medicine, 13(3). https://doi.org/10.1002/aid2.70042

Vancouver

Nikpour S, Salehi M, Abbasi M, Ghahremani A, Shiraji ST, Abasi S, et al. Comparison of the high‐dose dual therapy and standard quadruple therapy methods containing bismuth as the first line of treatment in eradicating Helicobacter pylori infection in Iran: A clinical trial study. Advances in Digestive Medicine. 2026;13(3). doi:10.1002/aid2.70042

BibTeX
@article{Nikpour2026,
  author = {Nikpour, Shahriar and Salehi, Mohammad and Abbasi, Maryam and Ghahremani, Ako and Shiraji, Sholeh Tavakoly and Abasi, Sara and Rokni, Mohsen},
  title = {Comparison of the high‐dose dual therapy and standard quadruple therapy methods containing bismuth as the first line of treatment in eradicating Helicobacter pylori infection in Iran: A clinical trial study},
  journal = {Advances in Digestive Medicine},
  year = {2026},
  volume = {13},
  number = {3},
  doi = {10.1002/aid2.70042}
}
Kostenlos starten →